Persistence of Rubella Antibodies after 2 Doses of Measles‐Mumps‐Rubella Vaccine | Zendy

Charles W. LeBaron | Zendy; Bagher Forghani | Zendy; L Matter | Zendy; Susan E. Reef | Zendy; Carol L. Beck | Zendy; Daoling Bi | Zendy; Cynthia Cossen | Zendy; Bradley J. Sullivan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Persistence of Rubella Antibodies after 2 Doses of Measles‐Mumps‐Rubella Vaccine

Author(s) -

Charles W. LeBaron,

Bagher Forghani,

L Matter,

Susan E. Reef,

Carol L. Beck,

Daoling Bi,

Cynthia Cossen,

Bradley J. Sullivan

Publication year - 2009

Publication title -

the journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.69

H-Index - 252

eISSN - 1537-6613

pISSN - 0022-1899

DOI - 10.1086/605410

Subject(s) - rubella , medicine , measles , titer , rubella vaccine , immunogenicity , immunology , antibody titer , antibody , vaccination , virology

Since 1990, most schoolchildren in the United States have received a second dose of measles-mumps-rubella vaccine (MMR2) at kindergarten entry. Elimination of endemic rubella virus circulation in the United States was declared in 2004. The objective of the current study was to evaluate the short- and long-term rubella immunogenicity of MMR2.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research